None listed
Conditions
Interventions
Intervention1: Face oil: Gently apply 4-5 drops of face oil dot wise twice a day (morning and evening) after washing the face. The product should be gently massaged using the fingertips in the upward
Sponsors
Antonio Puig S A Plaza
Eligibility
Inclusion criteria
Inclusion criteria: 1 Female subjects in general good health. 2 Subjects in the age group 18-35 years both ages inclusive 3 Subjects with blemishes like spots, pigmentation blackheads, PIH, acne, unevenness, scars on the face 4 Subjects willing to give written informed consent and willing to abide by and comply with the study protocol 5 Subjects who have not participated in a similar investigation in past two weeks. 6 Subjects willing to refrain from using any other product or home remedies that can impact the skin. 7 Subjects who agree not to participate in any other clinical study during participation in the current study.
Exclusion criteria
Exclusion criteria: 1 A known history or present condition of an allergic response/hypersensitivity to any cosmetic or skin pharmaceutical product. 2 Subject having active skin diseases like active atopic dermatitis, pigmented contact dermatitis or other cutaneous manifestation, which will interfere with the assessment. 3 Female subjects who are pregnant or lactating (Self declared). 4 Subjects who have undergone facial treatments in past 4 weeks. 5 Subjects on oral medications like topical or systemic corticosteroids, anti fungal, or antibiotics, or any prolonged use of non steroidal anti inflammatory, or anti histaminic within 2 weeks prior to the study, undergoing any chemical treatment-facial or bleach or waxing or which will compromise the study. 6 Subjects with any history of underlying uncontrolled medical illness including diabetes mellitus, hypertension, HIV, thyroid, hepatitis, severe anemia, serious disorder of the heart and respiratory apparatus or any other serious medical illness. 7 Employees of MSCR or the sponsor.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Reduction in skin blemishes (spots, pigmentation, blackheads, PIH, acne, unevenness, scars etc.)Timepoint: baseline, Week 2, Week 4, Week 8, Week 12. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1 Reduction in sebum (sebum control) production after test product usage analyzed by Sebumeter 2 Improvement in facial gloss and radiance after test product usage using Glossymeter. 3 Improvement in the skin barrier function after test product usage analyzed by Tewameter 4 Improvement in skin color after test product usage using Spectrophotometer. 5 Improvement in the skin hydration after test product usage analyzed by Corneometer 6 Improvement in the skin firmness after test product usage analysed by Cutometer 7 Evaluation of Safety and tolerability of the test productTimepoint: baseline, Week 2, Week 4, Week 8, Week 12. | — |
Countries
India
Contacts
Public ContactDr Mukta Sachdev
MS Clinical Research Pvt. Ltd.
Outcome results
None listed